A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial

Iron deficiency anemia (IDA) is prevalent, and intravenous iron, especially if given in a single dose, may result in better adherence compared with oral iron. The present trial (FERWON‐IDA) is part of the FERWON program with iron isomaltoside 1000/ferric derisomaltose (IIM), evaluating safety and ef...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Hematol
Päätekijät: Auerbach, Michael, Henry, David, Derman, Richard J., Achebe, Maureen M., Thomsen, Lars L., Glaspy, John
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2019
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6772897/
https://ncbi.nlm.nih.gov/pubmed/31243803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25564
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia